Abstract:RationaleTh2 cells play critical roles in the pathogenesis of allergic asthma. Established Th2 cells have been shown to resist reprogramming toward Th1 cells. We sought to understand the mechanisms by which asthmatic CD4+ T cells develop resistance to IL-27-mediated inhibition of Th2 differentiation.MethodsWe isolated and cultured CD4+ T cells from healthy individuals and allergic asthmatic patients and tested whether IL-27 can inhibit IL-4 production by the cultured CD4+ T cells using ELISA. STAT1 phosphorylation was analyzed by Western blot and flow cytometry. Suppressor of cytokine signaling (SOCS) mRNA expressions were measured by qPCR. The siRNA method was used to knockdown SOCS3 mRNA expression.ResultsWe demonstrate that CD4+ T cells from asthmatic patients resisted human IL-27-mediated suppression of IL-4 production. We observed that repeated exposures to Th2-inducing conditions rendered healthy human CD4+ T cells resistant to IL-27-mediated inhibition. Using an in vitro murine culture system, we further demonstrated that repeated or higher doses of IL-4, but not IL-2, stimulation upregulated SOCS3 mRNA expression and impaired IL-27-induced STAT1 phosphorylation. Py-STAT1 expression was impaired in Th2 memory cells circulating in peripheral blood isolated in asthmatics, but not in normal subjects. Knockdown of SOCS3 expression restored IL-27-mediated inhibition.ConclusionsOur findings demonstrate that differentiated Th2 cells can resist IL27-induced reprogramming toward Th1 cells by downregulating STAT1 phosphorylation and upregulation of SOCS3 and may explain why asthmatic CD4+ T cells are resistant to IL-27- mediated differential inhibition. RationaleTh2 cells play critical roles in the pathogenesis of allergic asthma. Established Th2 cells have been shown to resist reprogramming toward Th1 cells. We sought to understand the mechanisms by which asthmatic CD4+ T cells develop resistance to IL-27-mediated inhibition of Th2 differentiation. Th2 cells play critical roles in the pathogenesis of allergic asthma. Established Th2 cells have been shown to resist reprogramming toward Th1 cells. We sought to understand the mechanisms by which asthmatic CD4+ T cells develop resistance to IL-27-mediated inhibition of Th2 differentiation. MethodsWe isolated and cultured CD4+ T cells from healthy individuals and allergic asthmatic patients and tested whether IL-27 can inhibit IL-4 production by the cultured CD4+ T cells using ELISA. STAT1 phosphorylation was analyzed by Western blot and flow cytometry. Suppressor of cytokine signaling (SOCS) mRNA expressions were measured by qPCR. The siRNA method was used to knockdown SOCS3 mRNA expression. We isolated and cultured CD4+ T cells from healthy individuals and allergic asthmatic patients and tested whether IL-27 can inhibit IL-4 production by the cultured CD4+ T cells using ELISA. STAT1 phosphorylation was analyzed by Western blot and flow cytometry. Suppressor of cytokine signaling (SOCS) mRNA expressions were measured by qPCR. The siRNA method was used to knockdown SOCS3 mRNA expression. ResultsWe demonstrate that CD4+ T cells from asthmatic patients resisted human IL-27-mediated suppression of IL-4 production. We observed that repeated exposures to Th2-inducing conditions rendered healthy human CD4+ T cells resistant to IL-27-mediated inhibition. Using an in vitro murine culture system, we further demonstrated that repeated or higher doses of IL-4, but not IL-2, stimulation upregulated SOCS3 mRNA expression and impaired IL-27-induced STAT1 phosphorylation. Py-STAT1 expression was impaired in Th2 memory cells circulating in peripheral blood isolated in asthmatics, but not in normal subjects. Knockdown of SOCS3 expression restored IL-27-mediated inhibition. We demonstrate that CD4+ T cells from asthmatic patients resisted human IL-27-mediated suppression of IL-4 production. We observed that repeated exposures to Th2-inducing conditions rendered healthy human CD4+ T cells resistant to IL-27-mediated inhibition. Using an in vitro murine culture system, we further demonstrated that repeated or higher doses of IL-4, but not IL-2, stimulation upregulated SOCS3 mRNA expression and impaired IL-27-induced STAT1 phosphorylation. Py-STAT1 expression was impaired in Th2 memory cells circulating in peripheral blood isolated in asthmatics, but not in normal subjects. Knockdown of SOCS3 expression restored IL-27-mediated inhibition. ConclusionsOur findings demonstrate that differentiated Th2 cells can resist IL27-induced reprogramming toward Th1 cells by downregulating STAT1 phosphorylation and upregulation of SOCS3 and may explain why asthmatic CD4+ T cells are resistant to IL-27- mediated differential inhibition. Our findings demonstrate that differentiated Th2 cells can resist IL27-induced reprogramming toward Th1 cells by downregulating STAT1 phosphorylation and upregulation of SOCS3 and may explain why asthmatic CD4+ T cells are resistant to IL-27- mediated differential inhibition.

Impairment of IL-27's Differential Effect on CD4+T Cells in Asthma

Repeated Il-4 Stimulation Impairs Stat1 Signaling and Confers Cd4+T Cell Resistance to Il-27-Mediated Suppression

IL-4 Confers Resistance to IL-27–mediated Suppression on CD4+ T Cells by Impairing Signal Transducer and Activator of Transcription 1 Signaling

Il-4 Induces Th2 Cells To Resist The Il-27 Counterregulation By Downregulating Stat1 And Stat2 Phosphorylation

IL-27 Attenuates Airway Inflammation in a Mouse Asthma Model Via the STAT1 and GADD45γ/p38 MAPK Pathways

STAT3 and IL-6 Contribute to Corticosteroid Resistance in an OVA and Ozone-induced Asthma Model with Neutrophil Infiltration

Preventative Tracheal Administration of Interleukin-27 Attenuates Allergic Asthma by Improving the Lung Th1 Microenvironment

Preventative Administration of Il-27 Improves Airway Inflammation of Ovalbumin - Induced Asthma Mice Model Via Both Stat1 and Gadd45 Gamma/P38mapk Pathways

[Cytokine Profiles of CD4(+) T Memory Cells in Asthma and Their Relationship with Asthma Severity].

Induction Of Cd4(+)Cd25(+)Foxp3(+)Il-10(+) T Cells In Hdm-Allergic Asthmatic Children With Or Without Sit

The roles of thymic stromal lymphopoietin receptor and its antibody in airway inflammatory response in asthmatic mice

IL-27 Alleviates Airway Inflammation and Airway Hyperresponsiveness in Asthmatic Mice by Targeting the CD39/ATP Axis of Dendritic Cells

Reduced CCR6+IL-17A+Treg Cells in Blood and CCR6-Dependent Accumulation of IL-17A+Treg Cells in Lungs of Patients With Allergic Asthma

Early-life Undernutrition Reprograms CD4+ T-cell Glycolysis and Epigenetics to Facilitate Asthma.

Exploration of plasma interleukin-27 levels in asthma patients and the correlation with lung function

[Proliferation of T lymphocyte subsets in asthma patients in clinical remission and molecular mechanism thereof]

IL-27 Administration Via Nasal Improves OVA-Induced Airway Inflammation by GADD45ã but Not STAT1 Pathway

Tespa1 negatively modulates asthmatic attack is associated with IL-4/STAT-6 pathway of mast cell

Interferon-γ Stimulates Interleukin-27 Derived from Dendritic Cells to Regulate Th9 Differentiation through STAT1/3 Pathway

IL-27 Signaling Negatively Regulates FcɛRI-mediated Mast Cell Activation and Allergic Response

Lung Dysfunction in a Mouse Model of Inflammation is Dependent on T-cell-independent IL-13 Expression (54.18)